Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) EBIT (2020 - 2025)

Beauty Health (SKIN) has disclosed EBIT for 6 consecutive years, with $162000.0 as the latest value for Q4 2025.

  • Quarterly EBIT rose 102.26% to $162000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$20.8 million through Dec 2025, up 69.31% year-over-year, with the annual reading at -$20.8 million for FY2025, 69.31% up from the prior year.
  • EBIT for Q4 2025 was $162000.0 at Beauty Health, up from -$6.2 million in the prior quarter.
  • The five-year high for EBIT was $162000.0 in Q4 2025, with the low at -$82.1 million in Q3 2023.
  • Average EBIT over 5 years is -$14.4 million, with a median of -$11.3 million recorded in 2021.
  • The sharpest move saw EBIT tumbled 2226.51% in 2022, then surged 102.26% in 2025.
  • Over 5 years, EBIT stood at -$10.5 million in 2021, then skyrocketed by 76.69% to -$2.4 million in 2022, then tumbled by 650.0% to -$18.4 million in 2023, then skyrocketed by 61.02% to -$7.2 million in 2024, then soared by 102.26% to $162000.0 in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at $162000.0, -$6.2 million, and -$2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.